PROSTATE SPECIFIC ANTIGEN - A CRITICAL-ASSESSMENT OF THE MOST USEFUL TUMOR-MARKER FOR ADENOCARCINOMA OF THE PROSTATE

被引：1115

作者：

OESTERLING, JE

机构：

[1] Mayo Clinic, Rochester, MN 55905, 200 First St., S.W.

来源：

关键词：

PROSTATE; CARCINOMA; ADENOCARCINOMA; TUMOR MARKERS;

D O I：

10.1016/S0022-5347(17)38491-4

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：907 / 923

页数：17

共 116 条

[1] THE CHYMOTRYPSIN-LIKE ACTIVITY OF HUMAN PROSTATE-SPECIFIC ANTIGEN, GAMMA-SEMINOPROTEIN
AKIYAMA, K
NAKAMURA, T
IWANAGA, S
HARA, M
[J]. FEBS LETTERS, 1987, 225 (1-2) : 168 - 172
[2] ALFTHAN H, 1988, CLIN CHEM, V34, P2152
[3] EVALUATION OF PROSTATE SPECIFIC ACID-PHOSPHATASE AND PROSTATE SPECIFIC ANTIGEN IN IDENTIFICATION OF PROSTATIC-CANCER
ALLHOFF, EP
PROPPE, KH
CHAPMAN, CM
LIN, CW
PROUT, GR
MOSTOFI, FK
PONTES, JE
[J]. JOURNAL OF UROLOGY, 1983, 129 (02) : 315 - 318
[4] THE VALUE OF THE MEASUREMENT OF SERUM PROSTATE SPECIFIC ANTIGEN IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND UNTREATED PROSTATE-CANCER
ARMITAGE, TG
COOPER, EH
NEWLING, DWW
ROBINSON, MRG
APPLEYARD, I
[J]. BRITISH JOURNAL OF UROLOGY, 1988, 62 (06): : 584 - 589
[5] BAN Y, 1984, BIOCHEM BIOPH RES CO, V123, P482, DOI 10.1016/0006-291X(84)90256-0
[6] BILHARTZ DL, 1989, OCT MOL CELL BIOL PR
[7] BODOR G, 1989, CLIN CHEM, V35, P1262
[8] BOSTWICK DG, 1989, UROLOGY, V34, P16
[9] BRAWER M K, 1989, Journal of Endourology, V3, P227, DOI 10.1089/end.1989.3.227
[10] BRAWER MK, 1988, ARCH PATHOL LAB MED, V112, P1110